Carregant...
Measuring windows of selection for anti-malarial drug treatments
BACKGROUND: The long half-lives of malaria ‘partner’ drugs are a potent force selecting for drug resistance. Clinical trials can quantify this effect by estimating a window of selection (WoS), defined as the amount of time post-treatment when drug levels are sufficiently high that resistant parasite...
Guardat en:
| Publicat a: | Malar J |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4521485/ https://ncbi.nlm.nih.gov/pubmed/26228915 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-015-0810-4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|